Journal article
Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis
HC Martin, GE Kim, AT Pagnamenta, Y Murakami, GL Carvill, E Meyer, RR Copley, A Rimmer, G Barcia, MR Fleming, J Kronengold, MR Brown, KA Hudspith, J Broxholme, A Kanapin, JB Cazier, T Kinoshita, R Nabbout, D Bentley, G McVean Show all
Human Molecular Genetics | Published : 2014
DOI: 10.1093/hmg/ddu030
Abstract
In severe early-onset epilepsy, precise clinical and molecular genetic diagnosis is complex, as many metabolic and electro-physiological processes have been implicated in disease causation. The clinical phenotypes share many features such as complex seizure types and developmental delay. Molecular diagnosis has historically been confined to sequential testing of candidate genes known to be associated with specific sub-phenotypes, but the diagnostic yield of this approach can be low. We conducted whole-genome sequencing (WGS) on six patients with severe early-onset epilepsy who had previously been refractory to molecular diagnosis, and their parents. Four of these patients had a clinical diag..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
This work was supported in part by a Wellcome Trust Core Award (090532/Z/09/Z) to the Wellcome Trust Centre for Human Genetics and a Wellcome Trust Senior Investigator Award to P. D. (095552/2/11/2), in part by NIH grant HD067517 and in part by the Oxford NIHR Biomedical Research Centre. Funding to pay the Open Access publication charges for this article was provided by the wellcome Trust and the Oxford NIHR Biomedical Research Centre.